Search results
Novartis (NVS) Chronic Myeloid Leukemia Drug Approved by EC
Zacks via Yahoo News· 2 years agoNovartis NVS announced that the European Commission (EC) has approved Scemblix (asciminib) for the...
Heatwave Canada: How renters in Canada's big cities are beating the heat — and why it'll only get...
Yahoo News Canada· 1 week agoChildren cool off in a fountain as hot and humid weather continues in Toronto, Canada, on July 1,...
Humanigen (HGEN) Surges on Lenzilumab Study Data for Leukemia
Zacks via Yahoo News· 1 year agoHumanigen's (HGEN) shares surge after presenting promising early results of its Precision Approach...
Why Is Gilead (GILD) Up 1.9% Since Last Earnings Report?
Zacks via Yahoo News· 7 months agoIt has been about a month since the last earnings report for Gilead Sciences (GILD). Shares have...
Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?
Zacks via Yahoo News· 5 months agoWe expect Rigel Pharmaceuticals RIGL to beat expectations when it reports fourth-quarter and...
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
Zacks via Yahoo News· 2 years agoThis week, the FDA granted emergency approval to Pfizer PFE and partner BioNTech BNTX and Moderna’s...
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy
Zacks via Yahoo News· 7 months agoSwiss pharma giant Novartis NVS raised its sales and operating income goals for the mid-term, post...
Grieving Mom Feels Baby Girl’s Heart Beat Again When She Meets Toddler Organ Recipient
HuffPost via Yahoo News· 7 months agoA Kentucky woman whose baby girl died in January has found comfort amid her grief after meeting the...
Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study
Zacks via Yahoo News· 1 year agoPreliminary data from an ongoing mid-stage study shows that treatment with Biomea's (BMEA) lead...
Gilead (GILD) Gears Up to Report Q3 Earnings: What's in Store?
Zacks via Yahoo News· 8 months agoInvestors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales...